Jason C Hsu

11PUBLICATIONS
10CO-AUTHORS
Disease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseasePredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 21, 2026
Temporal trends in epidemiology and patient characteristics of 36 cancers: a protocol for a multinational population-based cohort study using OMOP-standardised databases to investigate CANcer (OMOPCAN).

|Jun 10, 2024
Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast cancer in Taiwan.

Tzu-Hsuan Tseng, Shao-Chin Chiang, Jason C Hsu

|Aug 26, 2022
Determinants of coronavirus disease 2019 infection by artificial intelligence technology: A study of 28 countries.

Hsiao-Ya Peng, Yen-Kuang Lin, Phung-Anh Nguyen

|May 13, 2020
Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series study.

Jason C Hsu, Chen-Fang Wei, Szu-Chun Yang

|Dec 13, 2019
Comprehensive value assessment of drugs using a multi-criteria decision analysis: An example of targeted therapies for metastatic colorectal cancer treatment.

Jason C Hsu, Jia-Yu Lin, Peng-Chan Lin

|Nov 12, 2019
Budget impact analysis of osteoporosis medications for primary prevention of fractures in Taiwan.

Kun-Ling Wu, Chih-Hsing Wu, Yin-Fan Chang

Pageof 2

Frequent Collaborators

1 joint publications

Carlos Lam

1 joint publications

Chang-I Chen

1 joint publications

Yu Ko

1 joint publications

Irene López-Sánchez